336 related articles for article (PubMed ID: 14719467)
1. A topical skin protectant against chemical warfare agents.
Kadar T; Fishbine E; Meshulam J; Sahar R; Amir A; Barness I
Isr Med Assoc J; 2003 Oct; 5(10):717-9. PubMed ID: 14719467
[TBL] [Abstract][Full Text] [Related]
2. Medical management of cutaneous sulfur mustard injuries.
Graham JS; Stevenson RS; Mitcheltree LW; Hamilton TA; Deckert RR; Lee RB; Schiavetta AM
Toxicology; 2009 Sep; 263(1):47-58. PubMed ID: 18762227
[TBL] [Abstract][Full Text] [Related]
3. Dermostyx (IB1) - High efficacy and safe topical skin protectant against percutaneous toxic agents.
Dachir S; Barness I; Fishbine E; Meshulam J; Sahar R; Eisenkraft A; Amir A; Kadar T
Chem Biol Interact; 2017 Apr; 267():25-32. PubMed ID: 27417258
[TBL] [Abstract][Full Text] [Related]
4. Characterization of acute and long-term sulfur mustard-induced skin injuries in hairless guinea-pigs using non-invasive methods.
Dachir S; Cohen M; Fishbeine E; Sahar R; Brandies R; Horwitz V; Kadar T
Skin Res Technol; 2010 Feb; 16(1):114-24. PubMed ID: 20384890
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of barrier creams against sulphur mustard: (II) In vivo and in vitro studies using the domestic white pig.
Chilcott RP; Dalton CH; Ashley Z; Allen CE; Bradley ST; Maidment MP; Jenner J; Brown RF; Gwyther RJ; Rice P
Cutan Ocul Toxicol; 2007; 26(3):235-47. PubMed ID: 17687688
[TBL] [Abstract][Full Text] [Related]
6. Ocular injuries following sulfur mustard exposure--pathological mechanism and potential therapy.
Kadar T; Dachir S; Cohen L; Sahar R; Fishbine E; Cohen M; Turetz J; Gutman H; Buch H; Brandeis R; Horwitz V; Solomon A; Amir A
Toxicology; 2009 Sep; 263(1):59-69. PubMed ID: 19061933
[TBL] [Abstract][Full Text] [Related]
7. Toxicology and pharmacology of the chemical warfare agent sulfur mustard.
Dacre JC; Goldman M
Pharmacol Rev; 1996 Jun; 48(2):289-326. PubMed ID: 8804107
[TBL] [Abstract][Full Text] [Related]
8. Long-term skin damage due to chemical weapon exposure.
Firooz A; Sadr B; Davoudi SM; Nassiri-Kashani M; Panahi Y; Dowlati Y
Cutan Ocul Toxicol; 2011 Mar; 30(1):64-8. PubMed ID: 21047269
[TBL] [Abstract][Full Text] [Related]
9. Acute and chronic effects of sulfur mustard on the skin: a comprehensive review.
Ghanei M; Poursaleh Z; Harandi AA; Emadi SE; Emadi SN
Cutan Ocul Toxicol; 2010 Dec; 29(4):269-77. PubMed ID: 20868209
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic options to treat sulfur mustard poisoning--the road ahead.
Smith WJ
Toxicology; 2009 Sep; 263(1):70-3. PubMed ID: 18852011
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of topical iodine containing anti-inflammatory drugs against sulfur mustard-induced skin lesions.
Wormser U; Sintov A; Brodsky B; Casillas RP; Nyska A
Arch Toxicol; 2004 Mar; 78(3):156-66. PubMed ID: 14618300
[TBL] [Abstract][Full Text] [Related]
12. Characterization of acute and long-term pathologies of superficial and deep dermal sulfur mustard skin lesions in the hairless guinea pig model.
Dachir S; Cohen M; Kamus-Elimeleh D; Fishbine E; Sahar R; Gez R; Brandeis R; Horwitz V; Kadar T
Wound Repair Regen; 2012; 20(6):852-61. PubMed ID: 23082902
[TBL] [Abstract][Full Text] [Related]
13. Mustard: a potential agent of chemical warfare and terrorism.
Saladi RN; Smith E; Persaud AN
Clin Exp Dermatol; 2006 Jan; 31(1):1-5. PubMed ID: 16309468
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical efficacy of topical pimecrolimus with betamethasone in chronic skin lesions due to sulfur mustard exposure: a randomized, investigator-blind study.
Panahi Y; Moharamzad Y; Beiraghdar F; Naghizadeh MM
Basic Clin Pharmacol Toxicol; 2009 Feb; 104(2):171-5. PubMed ID: 19143752
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the topical skin protectant in advanced development.
Liu DK; Wannemacher RW; Snider TH; Hayes TL
J Appl Toxicol; 1999 Dec; 19 Suppl 1():S40-5. PubMed ID: 10594900
[TBL] [Abstract][Full Text] [Related]
16. Estimates of percutaneous toxicity of sulfur mustard vapor suitable for use in protective equipment standards.
Dickson EF
J Toxicol Environ Health A; 2008; 71(20):1382-91. PubMed ID: 18704830
[TBL] [Abstract][Full Text] [Related]
17. Skin toxicokinetics of mustard gas in the guinea pig: effect of hypochlorite and safety aspects.
Wormser U; Brodsky B; Sintov A
Arch Toxicol; 2002 Sep; 76(9):517-22. PubMed ID: 12242609
[TBL] [Abstract][Full Text] [Related]
18. Early effects of iodine on DNA synthesis in sulfur mustard-induced skin lesions.
Brodsky B; Trivedi S; Peddada S; Flagler N; Wormser U; Nyska A
Arch Toxicol; 2006 Apr; 80(4):212-6. PubMed ID: 16252085
[TBL] [Abstract][Full Text] [Related]
19. Review of the U.S. Army's health risk assessments for oral exposure to six chemical-warfare agents. Introduction.
J Toxicol Environ Health A; 2000 Mar; 59(5-6):281-526. PubMed ID: 10742829
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of sulfur mustard skin injury following a topical treatment with a mixture of a steroid and a NSAID.
Dachir S; Fishbeine E; Meshulam Y; Sahar R; Chapman S; Amir A; Kadar T
J Appl Toxicol; 2004; 24(2):107-13. PubMed ID: 15052605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
